drugset / Trial / NCT04944303

The Feasibility of Sugammadex for General Anesthesia in Patients Undergoing Kidney and Pancreas Transplantation Surgery

NCT04944303

RandomizedParallel-groupOpen-labelTreatment

Summary

The effectiveness and safety of sugammadex were confirmed in pancreas kidney transplatation patients for reversal of deep neuromuscular blockade induced by rocuronium.Sugmmadex can reduce the length of PACU stay.

Timeline

Start
2020-12-18
Primary completion
2021-04-21
Completion
2021-04-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sugammadex Other / unclassified 4 mg/kg

Indications

No indication recorded.